Okuda Kunio, Yokosuka Osamu
Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
World J Gastroenterol. 2004 Aug 1;10(15):2209-12. doi: 10.3748/wjg.v10.i15.2209.
Hepatitis C virus (HCV) infection is very common among end-stage kidney disease patients on hemodialysis, but its natural history is not known.
In this study, 189 dialysis patients (case) positive for HCV antibodies who were followed up for more than 4 years were compared with twice as many sex/age matched controls with chronic hepatitis C who were diagnosed in the same month as the case and followed up for comparable periods. The longest follow-up was 23 years in dialysis cases. The disease activities were graded into "asymptomatic" if ALT was less than 40 (35 in cases) IU/L, "low activities" if ALT was 40 (35)-79 IU/L, and "high activities" if ALT was above 80 IU/L during the last or latest 4 year period.
All 25 dialysis cases who were followed up for more than 15 years were asymptomatic and 15 of them were negative for HCV RNA. Of the 50 controls followed up for more than 15 years, 34 had high activities, and none cleared HCV RNA. There were 60 controls who were asymptomatic, but they were all positive for HCV RNA, while 22.3% of asymptomatic dialysis cases were RNA negative. No dialysis patients with chronic hepatitis C progressed to cirrhosis, whereas the disease progressed to cirrhosis in more than one quarter of the controls. These differences were highly significant (P<0.0001).
Chronic hepatitic C among hemodialysis patients is mild in disease activity, and is not progressive, perhaps due to immunological abnormalities in these patients. Hepatic C virus is frequently cleared in asymptomatic dialysis patients during a long course. A possible mechanism for viral clearance is viral particle destruction on the surface of the dialyzer membrane.
丙型肝炎病毒(HCV)感染在接受血液透析的终末期肾病患者中非常常见,但其自然病程尚不清楚。
在本研究中,将189例HCV抗体阳性且随访超过4年的透析患者(病例组)与两倍数量的年龄和性别匹配的慢性丙型肝炎对照者进行比较,这些对照者与病例组在同一月份被诊断,且随访时间相当。透析病例的最长随访时间为23年。在最后或最近4年期间,如果丙氨酸氨基转移酶(ALT)低于40(病例组为35)IU/L,则疾病活动度分级为“无症状”;如果ALT为40(35)-79 IU/L,则为“低活动度”;如果ALT高于80 IU/L,则为“高活动度”。
所有25例随访超过15年的透析病例均无症状,其中15例HCV RNA检测为阴性。在50例随访超过15年的对照者中,34例有高活动度,且无一例清除HCV RNA。有60例对照者无症状,但他们的HCV RNA均为阳性,而22.3%的无症状透析病例RNA检测为阴性。没有慢性丙型肝炎的透析患者进展为肝硬化,而超过四分之一的对照者疾病进展为肝硬化。这些差异具有高度统计学意义(P<0.0001)。
血液透析患者中的慢性丙型肝炎疾病活动度较轻,且不会进展,这可能是由于这些患者存在免疫异常。在漫长病程中,无症状透析患者的丙型肝炎病毒常被清除。病毒清除的一种可能机制是透析器膜表面的病毒颗粒被破坏。